Mehr lesen
The second edition of this important book provides an up-to-date and comprehensive overview of clinical lipidology. Brand new chapters focus on recent advances in the field including novel biomarkers and the microbiome, genomics of cardiovascular risks, PCSK9 inhibitors, imaging technologies, and epidemiology of atherosclerotic cardiovascular disease.
The book describes new guidelines, novel therapeutic agents, and changes in the understanding of specific lipoproteins and subclasses with regard to their relationships to cardiovascular disease risk. The second edition contains more than thirty chapters covering such topics as the history of lipidology, lipoprotein metabolism and vascular biology, disorders of lipid metabolism, lifestyle/dietary and pharmacologic management for dyslipidemia, the management of dyslipidemia in certain subgroups (e.g., women, children, older patients) and lipid testing, as well as an examination of other biomarkers and testing procedures related toatherosclerosis and cardiovascular disease.
The second edition of Therapeutic Lipidology is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.
Über den Autor / die Autorin
Michael H. Davidson, MD
Professor, Director of the Lipid Clinic
The University of Chicago Pritzker School of Medicine
mdavidso@bsd.uchicago.edu
Peter P. Toth, MD, PhD
Director of Preventative Cardiology, CGH Medical Center
Professor of Clinical Family and Community Medicine, University of Illinois College of Medicine
Professor of Clinical Medicine, Michigan State University College of Osteopathic Medicine
Adjunct Associate Professor of Medicine, Johns Hopkins University School of Medicine
peter.toth@cghmc.com
Kevin C. Maki, PhD
President and Chief Scientist
Midwest Biomedical Research: Center for Metabolic & Cardiovascular Health
kmaki@mbclinicalresearch.com
Bericht
